DIA01-S

About Dianosic

Dianosic is a private, clinical-stage medtech company based in Lyon, France, pioneering an intranasal drug delivery platform. Its lead technology, the DIAXX Active Resorbable Intranasal Scaffold, is in preclinical development for chronic rhinitis (DIA01-R) and chronic rhinosinusitis (DIA01-S), with a longer-term 'Nose to Brain' program targeting CNS disorders. The company is currently pre-revenue, having raised €7M in late 2025, and has already commercialized its first product, the CAVI-T balloon for epistaxis, in Europe.

Therapeutic Areas